$1.42B
$14,000
0.0% of portfolio
16,465
Q3 2024
Added 0.21%
$67.6M
$175,000
0.0% of portfolio
74,472
Q3 2024
Reduced 52.08%
$361M
$446,000
0.0% of portfolio
34,463
Q3 2024
Reduced 40.74%
$2.29B
$754,000
0.0% of portfolio
75,096
Q3 2024
New
$154M
$186,000
0.0% of portfolio
135,500
Q3 2024
New
$32.6B
$800,000
0.0% of portfolio
4,497
Q3 2024
Reduced 0.53%
$199M
$122,000
0.0% of portfolio
37,170
Q3 2024
New
$4.54B
$2.51 Million
0.0% of portfolio
160,228
Q3 2024
Reduced 51.81%
$3.34B
$2.85 Million
0.0% of portfolio
58,190
Q3 2024
Reduced 45.9%
$4.52B
$2.39 Million
0.0% of portfolio
11,491
Q3 2024
New
$180M
$256,000
0.0% of portfolio
55,000
Q3 2024
Reduced 4.1%
$4.37B
$866,000
0.0% of portfolio
17,277
Q3 2024
Added 149.74%
$132M
$234,000
0.0% of portfolio
12,694
Q3 2024
Added 21.26%
$5.65B
$258,000
0.0% of portfolio
3,006
Q3 2024
New
$132M
$53,000
0.0% of portfolio
12,990
Q3 2024
New
$116M
$439,000
0.0% of portfolio
78,139
Q3 2024
New
$1.68B
$504,000
0.0% of portfolio
80,403
Q3 2024
Reduced 50.33%
$67.6B
$2.16 Million
0.0% of portfolio
13,276
Q3 2024
Added 39.04%
$725M
$597,000
0.0% of portfolio
71,959
Q3 2024
Reduced 79.76%
$1.52B
$2.73 Million
0.0% of portfolio
68,889
Q3 2024
Reduced 12.09%
$517M
$2.62 Million
0.0% of portfolio
173,774
Q3 2024
Reduced 25.1%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 47.06%
$588M
$2.87 Million
0.0% of portfolio
81,496
Q3 2024
Reduced 39.66%
Marinus Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 57.76%
$8.48B
$260,000
0.0% of portfolio
1,017
Q3 2024
Reduced 68.94%
$20M
$68,000
0.0% of portfolio
102,006
Q3 2024
Reduced 18.51%
Markforged Holding Corporati
-
$0
0.0% of portfolio
-
Q3 2024
New
$1.68B
$1.16 Million
0.0% of portfolio
236,241
Q3 2024
Added 9.33%
$1.26B
$470,000
0.0% of portfolio
26,581
Q3 2024
Reduced 34.7%
$10.6B
$2.31 Million
0.0% of portfolio
18,809
Q3 2024
Added 220.75%
$344M
$1.16 Million
0.0% of portfolio
63,524
Q3 2024
Added 530.26%
$9.28B
$262,000
0.0% of portfolio
6,942
Q3 2024
Reduced 3.57%
$2.04B
$234,000
0.0% of portfolio
2,092
Q3 2024
Reduced 45.62%
Matinas Biopharma Hldgs Inc
-
$0
0.0% of portfolio
-
Q3 2024
New
$596M
$201,000
0.0% of portfolio
11,877
Q3 2024
New
$324M
$454,000
0.0% of portfolio
39,456
Q3 2024
New
$5.28B
$1.94 Million
0.0% of portfolio
13,632
Q3 2024
New
$6.25B
$2.41 Million
0.0% of portfolio
126,569
Q3 2024
Reduced 88.23%
$418M
$559,000
0.0% of portfolio
143,817
Q3 2024
Reduced 0.12%
$342M
$511,000
0.0% of portfolio
143,214
Q3 2024
Added 55.35%
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
Added 45.04%
$2.71B
$1.24 Million
0.0% of portfolio
11,773
Q3 2024
New
$227M
$169,000
0.0% of portfolio
20,797
Q3 2024
Reduced 55.23%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 38.81%
$265M
$63,000
0.0% of portfolio
15,146
Q3 2024
Reduced 48.22%
$2.56B
$136,000
0.0% of portfolio
17,579
Q3 2024
New
$429M
$289,000
0.0% of portfolio
42,766
Q3 2024
Reduced 3.73%
$1.57B
$2.27 Million
0.0% of portfolio
50,445
Q3 2024
Added 57.93%
$3.69B
$933,000
0.0% of portfolio
14,828
Q3 2024
New